To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene LCORandC10orf12TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
266 supporting clones for gene LCORandC10orf12 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AK308356 thymus .a 1 to 2913 2 to 2913   tiling clone,   2913/2913
(100 %)
5 diff
(99.9 %id)
N29114 melanocyte .a 588 to 1087 1 to 500   tiling clone,   500/502
(99 %)
5 diff
(99.1 %id)
BQ310465 breast .a 836 to 1162 390 to 49       342/396
(86 %)
0 diff
(100 %id)
AI902635 breast .a 935 to 1121 1 to 187   tiling clone,   187/195
(95 %)
3 diff
(98.5 %id)
BG460480   .a 1028 to 1656 637 to 1     Submitted on the opposite strand 637/694
(91 %)
15 diff
(97.9 %id)
AI902741 breast .a 1182 to 1483 302 to 1       302/302
(100 %)
5 diff
(98.4 %id)
AK126886 amygdala .a 1275 to 4920 1 to 3646   available from FLJ,   3646/3646
(100 %)
3 diff
(100.0 %id)
DA194125 amygdala .a 1276 to 1860 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
BC024315 Pancreas, epithelioid carcinoma .a 1328 to 5871 1 to 4544   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 4544/4544
(100 %)
0 diff
(100 %id)
NM_015652.2   .a 1328 to 5871 1 to 4544   RefSeq, AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 4544/4544
(100 %)
0 diff
(100 %id)
BE907891 epithelioid carcinoma, Pancreas .a 1348 to 2156 1 to 790       790/934
(84 %)
45 diff
(95.2 %id)
TI_1948150664   .a 1426 to 2213 119 to 916       798/1453
(54 %)
6 diff
(99.6 %id)
TI_1948150665   .a 1426 to 2171 115 to 863       749/1049
(71 %)
6 diff
(99.5 %id)
TI_1948150926   .a 1426 to 2174 121 to 876       756/1425
(53 %)
6 diff
(99.6 %id)
TI_1948150927   .a 1426 to 2160 118 to 864       747/1085
(68 %)
6 diff
(99.5 %id)
TI_1948151194   .a 1426 to 2320 125 to 1021       897/1340
(66 %)
6 diff
(99.6 %id)
TI_1948151470   .a 1426 to 2166 119 to 869       751/1462
(51 %)
6 diff
(99.6 %id)
TI_1948151471   .a 1426 to 2156 119 to 852       734/1071
(68 %)
6 diff
(99.5 %id)
TI_1948151195   .a 1435 to 2088 129 to 788       660/1096
(60 %)
14 diff
(98.8 %id)
EL733160 mixed .a 1451 to 1911 16 to 478       463/478
(96 %)
6 diff
(98.8 %id)
AI902742 breast .a 1496 to 1840 345 to 1       345/345
(100 %)
1 diff
(99.8 %id)
CR990185 T-Lymphocytes .a 1710 to 2389 1 to 680       680/688
(98 %)
4 diff
(99.5 %id)
BC031482 Testis, embryonal carcinoma .a 1931 to 4889 1 to 2959   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 2959/2969
(99 %)
1 diff
(100.0 %id)
BG257754 embryonal carcinoma, cell line, testis .a 1932 to 2628 1 to 692   available from MGC,   692/696
(99 %)
9 diff
(98.8 %id)
DR001524 fetal brain .a 2087 to 2774 1 to 686       686/686
(100 %)
10 diff
(98.6 %id)
AK023084   .a 2139 to 5867 1 to 3729   available from FLJ,   3729/3729
(100 %)
3 diff
(100.0 %id)
AU130389   .a 2140 to 2892 2 to 754   capped   753/754
(99 %)
10 diff
(98.7 %id)
AA627752 colon, colon tumor RER+ .a 2433 to 2912 480 to 1       480/480
(100 %)
1 diff
(99.8 %id)
BG232093 blood, lymphocyte .a 2444 to 2909 466 to 1       466/466
(100 %)
0 diff
(100 %id)
AL042598 testis .a 2520 to 3153 1 to 639     Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 639/650
(98 %)
5 diff
(99.3 %id)
BE613572 leiomyosarcoma, uterus .a 2564 to 3380 1 to 803       803/812
(98 %)
21 diff
(97.5 %id)
AV760888 bone marrow .a 2683 to 3347 1 to 658       658/661
(99 %)
11 diff
(98.4 %id)
BI517661 pooled colon, kidney, stomach .a 2835 to 3707 1 to 869       869/870
(99 %)
20 diff
(97.8 %id)
TI_45236559   .a 2835 to 3707 59 to 927       869/928
(93 %)
20 diff
(97.9 %id)
BG009320 placenta_normal .a 2876 to 3392 15 to 531       517/531
(97 %)
6 diff
(98.9 %id)
BQ723372 sympathetic trunk .a 2904 to 3807 44 to 948       905/948
(95 %)
8 diff
(99.2 %id)
BI024409 marrow .a 3092 to 3512 14 to 434       421/434
(97 %)
6 diff
(98.7 %id)
BI028183 marrow .a 3092 to 3520 14 to 451       438/451
(97 %)
6 diff
(98.7 %id)
BQ365386 placenta_normal .a 3258 to 3559 306 to 3       304/306
(99 %)
0 diff
(100 %id)
BQ365393 placenta_normal .a 3258 to 3546 289 to 1       289/289
(100 %)
1 diff
(99.7 %id)
BQ365521 placenta_normal .a 3258 to 3554 1 to 297       297/298
(99 %)
2 diff
(99.4 %id)
BQ365522 placenta_normal .a 3258 to 3546 1 to 289       289/289
(100 %)
2 diff
(99.4 %id)
BF911287 uterus_tumor .a 3331 to 3695 367 to 4     Submitted on the opposite strand 364/367
(99 %)
0 diff
(100 %id)
BG257177 embryonal carcinoma, cell line, testis .a 3386 to 4082 1 to 698       698/1214
(57 %)
12 diff
(99.1 %id)
CX784490 human embryonic stem cells .a 3767 to 4579 1 to 813       813/813
(100 %)
0 diff
(100 %id)
AA304931 colon .a 3777 to 4260 1 to 484       484/484
(100 %)
4 diff
(99.2 %id)
AW961159   .a 3785 to 4460 1 to 680       680/701
(97 %)
22 diff
(96.9 %id)
W02575 melanocyte .a 3999 to 4548 1 to 557       557/557
(100 %)
11 diff
(98.1 %id)
TI_1948150667   .a 4120 to 5177 1184 to 130       1055/1330
(79 %)
0 diff
(100 %id)
TI_1948150666   .a 4280 to 5177 1034 to 128       907/1247
(72 %)
0 diff
(100 %id)
BF992779 placenta_normal .a 4355 to 4698 359 to 20       340/569
(59 %)
0 diff
(100 %id)
TI_1948151196   .a 4365 to 5177 945 to 121       825/1297
(63 %)
0 diff
(100 %id)
CB139673 Liver .a 4372 to 4689 1 to 318       318/318
(100 %)
1 diff
(99.7 %id)
DB303484 amygdala .a 4391 to 4920 530 to 1       530/530
(100 %)
0 diff
(100 %id)
TI_1948150929   .a 4395 to 5177 928 to 125       804/1459
(55 %)
0 diff
(100 %id)
TI_1948151197   .a 4395 to 5177 915 to 128       788/1435
(54 %)
0 diff
(100 %id)
TI_1948151472   .a 4418 to 5177 896 to 125       772/1348
(57 %)
0 diff
(100 %id)
AL049938 brain .a 4507 to 5773 1 to 1267   available from DKFZ, AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 1267/1267
(100 %)
0 diff
(100 %id)
TI_1948151473   .a 4600 to 5177 706 to 128       579/1383
(41 %)
0 diff
(100 %id)
BX279707 adenocarcinoma, colon .a 4715 to 5202 1 to 488       488/488
(100 %)
0 diff
(100 %id)
BF903408 marrow .a 4833 to 5323 491 to 1     Submitted on the opposite strand 491/494
(99 %)
35 diff
(93.0 %id)
BF881434 lung_tumor .a 4841 to 5375 12 to 546       535/546
(97 %)
6 diff
(99.0 %id)
BQ309177 breast .a 4998 to 5512 17 to 530       514/530
(96 %)
11 diff
(98.0 %id)
BE966470 leiomyosarcoma, uterus .a 5245 to 5928 710 to 14       697/756
(92 %)
0 diff
(100 %id)
BP356121   .a 5247 to 5829 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
DA747371   .a 5256 to 5793 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
AU152359   .a 5308 to 5867 554 to 1       554/556
(99 %)
12 diff
(97.9 %id)
BE614288 leiomyosarcoma, uterus .a 5321 to 5848 542 to 5       538/989
(54 %)
0 diff
(100 %id)
AI655077 pooled germ cell tumors .a 5356 to 5779 425 to 3       423/425
(99 %)
0 diff
(100 %id)
BI518372 pooled colon, kidney, stomach .a 5379 to 5877 523 to 2       522/524
(99 %)
0 diff
(100 %id)
TI_45236560   .a 5379 to 5877 523 to 2       522/524
(99 %)
0 diff
(100 %id)
AI310447 adenocarcinoma, colon .a 5407 to 5867 461 to 1       461/461
(100 %)
0 diff
(100 %id)
BF970456 adrenal cortex carcinoma, cell line, adrenal gland .a 5476 to 6182 1 to 708       708/842
(84 %)
20 diff
(97.7 %id)
AL042599 testis .a 5602 to 6250 667 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 650/650
(100 %)
1 diff
(99.9 %id)
N73475 melanocyte .a 5715 to 5925 211 to 1       211/211
(100 %)
0 diff
(100 %id)
AI571097 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 5880 to 6256 394 to 18   AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 377/377
(100 %)
0 diff
(100 %id)
AW503013 lymph .a 6111 to 6421 1 to 311       311/311
(100 %)
4 diff
(98.8 %id)
TI_154158711   .a 6117 to 6606 89 to 587   tiling clone,   499/546
(91 %)
23 diff
(95.8 %id)
CB105116 Ascites, stomach .a 6388 to 6990 1 to 603   tiling clone,   603/603
(100 %)
1 diff
(99.9 %id)
CA313138 Human Lung Epithelial cells, lung .a 6413 to 7187 795 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 777/777
(100 %)
2 diff
(99.8 %id)
AL834245 human skeletal muscle .b 1 to 4834 1 to 4834 V36A S503P tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 4834/4835
(99 %)
8 diff
(99.9 %id)
DR000812 fetal brain .b 9 to 330 1 to 322   tiling clone,   322/323
(99 %)
4 diff
(98.8 %id)
NM_001170765.1   .c 1 to 10369 2 to 10370 exact RefSeq,   10370/10370
(100 %)
3 diff
(100.0 %id)
AL832106 bone marrow .c 20 to 4827 1 to 4809 Q116P tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 4809/4810
(99 %)
5 diff
(99.9 %id)
AL832044 human bone marrow .c 1241 to 4815 1 to 3574   available from DKFZ, AAA Possibly primed on the genome, locally A rich (31/35 A in genome downstream of last aligned base) 3574/3575
(99 %)
5 diff
(99.9 %id)
CN365691 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 1460 to 1977 1 to 518       518/518
(100 %)
0 diff
(100 %id)
AK095345 tongue, tumor tissue .c 1638 to 4828 1 to 3193   tiling clone, available from FLJ,   3193/3193
(100 %)
2 diff
(100.0 %id)
DA443362 tongue, tumor tissue .c 1639 to 2166 2 to 530   capped   529/529
(100 %)
1 diff
(99.9 %id)
CB270113 adipose .c 1810 to 2166 1 to 357       357/357
(100 %)
1 diff
(99.8 %id)
AA081924   .c 1886 to 2392 1 to 504       504/532
(94 %)
4 diff
(99.3 %id)
AI826032 lymph node, lymphoma, follicular mixed small and largecell .c 1931 to 2346 416 to 1       416/416
(100 %)
0 diff
(100 %id)
AW139546   .c 2003 to 2337 1 to 334     Submitted on the opposite strand 334/344
(97 %)
9 diff
(97.4 %id)
DA884778   .c 2016 to 2600 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
BM153812 leukopheresis .c 2360 to 2931 572 to 1       572/572
(100 %)
1 diff
(99.9 %id)
AK023248   .c 2560 to 4828 1 to 2268   tiling clone, available from FLJ,   2268/2268
(100 %)
1 diff
(100.0 %id)
AU132324   .c 2561 to 3383 2 to 816   capped   815/815
(100 %)
11 diff
(98.7 %id)
CA391495 eye, RPE/choroid .c 2653 to 3048 1 to 396   fully sequenced,   396/396
(100 %)
0 diff
(100 %id)
BM829125 Ascites, stomach .c 2843 to 3082 1 to 240       240/240
(100 %)
0 diff
(100 %id)
FN091054 breast carcinoma .c 2896 to 2978 1 to 82       82/82
(100 %)
3 diff
(96.4 %id)
FN057134 breast carcinoma .c 2923 to 3027 1 to 105       105/105
(100 %)
0 diff
(100 %id)
CA391494 eye, RPE/choroid .c 3018 to 3507 506 to 17   fully sequenced, AAA   490/490
(100 %)
0 diff
(100 %id)
BF432503 pooled .c 3097 to 3368 1 to 272     Submitted on the opposite strand 272/272
(100 %)
0 diff
(100 %id)
AV709918 adrenal gland .c 3099 to 3513 1 to 415       415/415
(100 %)
1 diff
(99.8 %id)
BF058274 fibrotheoma, ovary .c 3105 to 3501 1 to 397     Submitted on the opposite strand 397/397
(100 %)
1 diff
(99.8 %id)
BF435999 pooled .c 3112 to 3475 1 to 364     Submitted on the opposite strand 364/364
(100 %)
3 diff
(99.2 %id)
DN913833   .c 3337 to 3708 1 to 372       372/372
(100 %)
0 diff
(100 %id)
BY797861 eye .c 3339 to 3924 1 to 586       586/586
(100 %)
0 diff
(100 %id)
N75641 liver and spleen .c 3412 to 3924 14 to 530       517/530
(97 %)
9 diff
(98.4 %id)
CN365689 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 3920 to 4494 1 to 575       575/575
(100 %)
2 diff
(99.7 %id)
FN080495 breast carcinoma .c 3933 to 4024 1 to 88       88/94
(93 %)
4 diff
(95.8 %id)
AA429975   .c 3997 to 4386 1 to 390       390/390
(100 %)
0 diff
(100 %id)
BF082013 amnion_normal .c 4014 to 4279 1 to 262       262/262
(100 %)
6 diff
(97.8 %id)
BF095722 uterus_tumor .c 4148 to 4321 1 to 174       174/174
(100 %)
0 diff
(100 %id)
BM998179 lung, Metastatic Chondrosarcoma .c 4175 to 4832 656 to 1   tiling clone,   656/656
(100 %)
2 diff
(99.7 %id)
AW583070 Islets of Langerhans, Pancreas .c 4197 to 4662 1 to 466       466/466
(100 %)
2 diff
(99.6 %id)
CK905040 Islets of Langerhans, Pancreas .c 4197 to 4771 1 to 575       575/575
(100 %)
0 diff
(100 %id)
FN126800 breast carcinoma .c 4265 to 4359 1 to 95       95/95
(100 %)
0 diff
(100 %id)
AW663968 pooled .c 4267 to 4828 562 to 1       562/562
(100 %)
0 diff
(100 %id)
AU153869   .c 4267 to 4828 560 to 1       560/560
(100 %)
8 diff
(98.6 %id)
DB313835 tongue, tumor tissue .c 4284 to 4828 545 to 1       545/545
(100 %)
0 diff
(100 %id)
DN913834   .c 4290 to 4813 524 to 1       524/524
(100 %)
1 diff
(99.9 %id)
AI806239 pooled .c 4311 to 4828 518 to 1       518/521
(99 %)
0 diff
(100 %id)
AI799125 pooled .c 4318 to 4828 511 to 1       511/511
(100 %)
0 diff
(100 %id)
NM_001170766.1   .d 1 to 7792 2 to 7793 exact RefSeq,   7793/7793
(100 %)
3 diff
(100.0 %id)
DB441976 testis .d 4 to 438 1 to 436   tiling clone,   436/436
(100 %)
11 diff
(97.5 %id)
CN265508 embryonic stem cells, cell lines H1, H7, andH9 .d 10 to 206 1 to 197   tiling clone,   197/197
(100 %)
4 diff
(98.0 %id)
BC053359 Lung, large cell carcinoma .d 59 to 2251 1 to 2193 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 2193/2193
(100 %)
0 diff
(100 %id)
BU153548 large cell carcinoma, lung .d 59 to 911 23 to 877       855/878
(97 %)
9 diff
(99.0 %id)
TI_1948216102   .d 542 to 1264 132 to 864   fully sequenced,   733/864
(84 %)
12 diff
(98.7 %id)
TI_1948216263   .d 542 to 1415 129 to 1017   fully sequenced,   889/1017
(87 %)
21 diff
(98.0 %id)
TI_1948216421   .d 542 to 1402 128 to 990   fully sequenced,   863/990
(87 %)
13 diff
(98.7 %id)
TI_1948216580   .d 542 to 1468 129 to 1053   fully sequenced, AAA   925/1053
(87 %)
20 diff
(98.2 %id)
EL734771 mixed .d 543 to 1198 1 to 656       656/656
(100 %)
0 diff
(100 %id)
BC128542 PCR rescued clones .d 608 to 1394 13 to 799       787/806
(97 %)
7 diff
(99.2 %id)
BF677797 Prostate .d 874 to 1417 14 to 579       566/788
(71 %)
34 diff
(95.7 %id)
DA410085 thalamus .d 1019 to 1575 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA410092 thalamus .d 1019 to 1531 2 to 515   capped   514/514
(100 %)
1 diff
(99.9 %id)
BQ333650 marrow .d 1130 to 1530 412 to 14       399/412
(96 %)
0 diff
(100 %id)
TI_1948216103   .d 1234 to 1761 661 to 125   fully sequenced,   537/661
(81 %)
5 diff
(99.3 %id)
TI_1948216422   .d 1372 to 1761 517 to 124   fully sequenced,   394/517
(76 %)
5 diff
(99.1 %id)
TI_1948216264   .d 1385 to 1761 511 to 127   fully sequenced,   385/511
(75 %)
5 diff
(99.1 %id)
TI_1948216581   .d 1438 to 1761 449 to 125   fully sequenced,   325/449
(72 %)
5 diff
(98.9 %id)
N64794.
matches multiple genes
multiple sclerosis lesions .d 1722 to 2252 537 to 1     also hits gene ATF6BandTNXB 537/543
(98 %)
24 diff
(95.6 %id)
AW468300 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .d 1754 to 2143 390 to 1       390/390
(100 %)
0 diff
(100 %id)
CN365690 embryonic stem cells, cell lines H1, H7, andH9 .d 1759 to 2347 1 to 588   tiling clone,   588/588
(100 %)
2 diff
(99.7 %id)
FN150467 breast carcinoma .d 1780 to 1883 104 to 1     Submitted on the opposite strand 104/104
(100 %)
3 diff
(97.2 %id)
AW418690 pooled .d 1796 to 2236 456 to 16   AAA Possibly primed on the genome, locally A rich (11/12 A in genome downstream of last aligned base) 441/441
(100 %)
0 diff
(100 %id)
AI393626 pooled .d 1802 to 2251 450 to 1       450/450
(100 %)
3 diff
(99.4 %id)
AA806691 germinal center B cell .d 1847 to 2143 297 to 1       297/297
(100 %)
0 diff
(100 %id)
FN166239 breast carcinoma .d 1888 to 2010 123 to 1     Submitted on the opposite strand 123/123
(100 %)
1 diff
(99.2 %id)
AA446131   .d 1895 to 2254 360 to 1       360/360
(100 %)
6 diff
(98.4 %id)
AV740506 cord Blood .d 1966 to 2249 42 to 321   AAA Possibly primed on the genome, locally A rich (26/29 A in genome downstream of last aligned base) 280/321
(87 %)
6 diff
(98.2 %id)
AA812098 germinal center B cell .d 1992 to 2143 152 to 1       152/152
(100 %)
2 diff
(98.7 %id)
AA342019 Spleen .d 2059 to 2236 178 to 1       178/178
(100 %)
0 diff
(100 %id)
DW456981 Liver .d 2139 to 2234 17 to 112   AAA Possibly primed on the genome, locally A rich (31/35 A in genome downstream of last aligned base) 96/115
(83 %)
1 diff
(99.2 %id)
CV338351 breast_normal .d 2367 to 2510 148 to 1   tiling clone, Submitted on the opposite strand 148/153
(96 %)
5 diff
(96.8 %id)
AL589575 human spinal cord .d 2401 to 2763 28 to 390   tiling clone,   363/390
(93 %)
6 diff
(98.5 %id)
CV373484 prostate_tumor .d 2517 to 2733 265 to 46     Submitted on the opposite strand 220/265
(83 %)
0 diff
(100 %id)
AI684720 pooled .d 2725 to 3042 472 to 155   tiling clone,   318/472
(67 %)
0 diff
(100 %id)
BM147735 leukopheresis .d 2819 to 3339 1 to 521   tiling clone,   521/521
(100 %)
1 diff
(99.9 %id)
AL704685 human skeletal muscle .d 2959 to 3187 1 to 231       231/231
(100 %)
6 diff
(97.5 %id)
BE150299 head_neck .d 3313 to 3691 438 to 50   tiling clone, Submitted on the opposite strand 389/447
(87 %)
23 diff
(94.9 %id)
AL699926 human skeletal muscle .d 3505 to 4220 1 to 714   tiling clone,   714/714
(100 %)
4 diff
(99.5 %id)
DB226681 trachea .d 3522 to 4095 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
CN285221 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 3538 to 3974 1 to 437       437/437
(100 %)
0 diff
(100 %id)
DA247265 brain .d 3684 to 4283 2 to 601   capped   600/600
(100 %)
0 diff
(100 %id)
BX954885   .d 3798 to 4372 1 to 575   tiling clone,   575/575
(100 %)
0 diff
(100 %id)
AV660279 corresponding non cancerous liver tissue .d 4408 to 4825 7 to 424     Submitted on the opposite strand 418/424
(98 %)
9 diff
(97.9 %id)
AV660348 corresponding non cancerous liver tissue .d 4408 to 4824 7 to 423   tiling clone, Submitted on the opposite strand 417/423
(98 %)
9 diff
(97.9 %id)
AV660361 corresponding non cancerous liver tissue .d 4408 to 4823 7 to 422     Submitted on the opposite strand 416/422
(98 %)
8 diff
(98.2 %id)
DA757629   .d 4471 to 5026 2 to 557   tiling clone, capped   556/556
(100 %)
1 diff
(99.9 %id)
BU430149 lymph .d 4511 to 4919 1 to 409       409/409
(100 %)
10 diff
(97.6 %id)
TI_154151462   .d 4518 to 5042 82 to 606   tiling clone,   525/526
(99 %)
7 diff
(98.7 %id)
AL599624   .d 5231 to 5806 1 to 576   tiling clone,   576/576
(100 %)
1 diff
(99.9 %id)
AB072899   .d 5250 to 7787 1 to 2538   tiling clone,   2538/2543
(99 %)
2 diff
(100.0 %id)
AU253889 neuroblastoma .d 5250 to 5921 26 to 696       671/697
(96 %)
8 diff
(98.9 %id)
DA752661   .d 5354 to 5931 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DA144394 amygdala .d 5388 to 5963 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
AA331588 Embryo, 8 weeks .d 5404 to 5731 1 to 332       332/332
(100 %)
4 diff
(98.8 %id)
AA337217 endometrium .d 5462 to 5726 1 to 265       265/265
(100 %)
0 diff
(100 %id)
AW966217   .d 5493 to 6115 1 to 615       615/620
(99 %)
40 diff
(93.6 %id)
DB124376 thymus .d 5529 to 6082 2 to 557   capped   556/556
(100 %)
2 diff
(99.7 %id)
BM458992 melanotic melanoma, skin .d 5649 to 6643 1 to 1006       1006/1038
(96 %)
29 diff
(97.3 %id)
DA363286 subthalamic nucleus .d 5765 to 6311 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA493509 brain .d 5767 to 6341 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
N47352 multiple sclerosis lesions .d 5788 to 6135 1 to 355       355/374
(94 %)
11 diff
(97.1 %id)
DA016693 adrenal gland .d 5800 to 6253 2 to 455   capped   454/454
(100 %)
0 diff
(100 %id)
AU254017 neuroblastoma .d 5884 to 6523 1 to 649     Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 649/658
(98 %)
19 diff
(97.2 %id)
DA257901 caudate nucleus .d 5887 to 6435 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA357634 subthalamic nucleus .d 5962 to 6525 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
BX505363   .d 5973 to 6633 1 to 661       661/661
(100 %)
7 diff
(99.0 %id)
DA911446   .d 5998 to 6552 2 to 556   capped   555/555
(100 %)
2 diff
(99.7 %id)
N28512 melanocyte .d 6115 to 6588 1 to 474       474/474
(100 %)
4 diff
(99.2 %id)
CB127192 cervix, Uterine .d 6218 to 6815 1 to 596       596/596
(100 %)
1 diff
(99.9 %id)
BG403514 bladder, transitional cell papilloma, cell line .d 6249 to 6912 1 to 673       673/703
(95 %)
13 diff
(98.2 %id)
BG528070 lung, mucoepidermoid carcinoma .d 6308 to 6932 1 to 623       623/849
(73 %)
14 diff
(98.4 %id)
CN349140 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 6343 to 6814 1 to 472       472/472
(100 %)
0 diff
(100 %id)
H82165 melanocyte .d 6425 to 6753 1 to 333       333/334
(99 %)
10 diff
(97.1 %id)
N24494 melanocyte .d 6470 to 6864 1 to 396       396/396
(100 %)
3 diff
(99.3 %id)
AA447186   .d 6496 to 6922 1 to 426       426/426
(100 %)
3 diff
(99.3 %id)
DT217712 brain .d 6566 to 7311 1 to 746       746/746
(100 %)
0 diff
(100 %id)
BG009801 placenta_normal .d 6582 to 7099 1 to 517       517/520
(99 %)
13 diff
(97.5 %id)
CN260464 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 6590 to 7234 1 to 645       645/645
(100 %)
4 diff
(99.4 %id)
BG009799 placenta_normal .d 6591 to 7113 18 to 541       524/541
(96 %)
6 diff
(98.9 %id)
BG009802 placenta_normal .d 6591 to 7138 2 to 546       545/546
(99 %)
6 diff
(99.0 %id)
BG009806 placenta_normal .d 6591 to 6801 16 to 229       214/236
(90 %)
11 diff
(95.4 %id)
BM749359 stomach .d 6616 to 7191 1 to 575       575/575
(100 %)
1 diff
(99.9 %id)
BG428221 Kidney .d 6660 to 7337 1 to 682       682/682
(100 %)
7 diff
(99.0 %id)
TI_149314521   .d 6668 to 7510 923 to 88   AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 836/970
(86 %)
10 diff
(99.0 %id)
BM699205 eye, fetal eyes .d 6668 to 7193 1 to 526     Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 526/549
(95 %)
8 diff
(98.6 %id)
BE782824 eye, retinoblastoma .d 6718 to 7448 1 to 727       727/734
(99 %)
16 diff
(97.9 %id)
BG435409 placenta .d 6744 to 7299 1 to 559       559/559
(100 %)
5 diff
(99.2 %id)
BG009808 placenta_normal .d 6760 to 7226 490 to 23       468/495
(94 %)
0 diff
(100 %id)
CN269831 embryonic stem cells, DMSO-treated H9 cellline .d 6785 to 7384 1 to 600       600/600
(100 %)
1 diff
(99.9 %id)
BG434442 placenta .d 6805 to 7592 1 to 779       779/794
(98 %)
32 diff
(96.0 %id)
CB306150 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 6881 to 7510 648 to 19   AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 630/630
(100 %)
0 diff
(100 %id)
AW381569 head_neck .d 6884 to 7408 525 to 3       523/525
(99 %)
0 diff
(100 %id)
CB114598 Liver .d 6915 to 7520 1 to 605       605/605
(100 %)
2 diff
(99.7 %id)
CB147041 Liver .d 6932 to 7464 1 to 532       532/532
(100 %)
3 diff
(99.5 %id)
FN118654 breast carcinoma .d 6941 to 7020 80 to 1     Submitted on the opposite strand 80/80
(100 %)
1 diff
(98.8 %id)
AW023535 cochlea, ear .d 6966 to 7379 1 to 415       415/415
(100 %)
6 diff
(98.6 %id)
BF792540 adrenal cortex carcinoma, cell line, adrenal gland .d 7002 to 7707 1 to 702       702/710
(98 %)
12 diff
(98.4 %id)
BU633403 cell lines, Chondrosarcoma .d 7037 to 7776 758 to 19   AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 740/740
(100 %)
3 diff
(99.6 %id)
N45471 multiple sclerosis lesions .d 7113 to 7470 1 to 358       358/370
(96 %)
3 diff
(99.2 %id)
AU254018 neuroblastoma .d 7117 to 7774 697 to 39   AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 659/662
(99 %)
3 diff
(99.6 %id)
BP425810 small intestine .d 7127 to 7436 1 to 310     Submitted on the opposite strand 310/310
(100 %)
0 diff
(100 %id)
AU253890 neuroblastoma .d 7139 to 7793 643 to 2       642/684
(93 %)
0 diff
(100 %id)
EH346873   .d 7149 to 7238 1 to 90       90/90
(100 %)
0 diff
(100 %id)
BP425344 small intestine .d 7157 to 7644 13 to 500     Submitted on the opposite strand 488/500
(97 %)
6 diff
(98.8 %id)
AV720680 corresponding non cancerous liver tissue .d 7179 to 7771 593 to 1     Submitted on the opposite strand 593/593
(100 %)
0 diff
(100 %id)
AV720584 corresponding non cancerous liver tissue .d 7182 to 7776 595 to 1     Submitted on the opposite strand 595/595
(100 %)
4 diff
(99.4 %id)
AV719292 corresponding non cancerous liver tissue .d 7182 to 7777 596 to 1     Submitted on the opposite strand 596/596
(100 %)
0 diff
(100 %id)
AI831506 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .d 7213 to 7781 579 to 11       569/579
(98 %)
0 diff
(100 %id)
BM669865 eye, fetal eyes .d 7223 to 7784 580 to 19   AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 562/562
(100 %)
2 diff
(99.7 %id)
DB349731 trachea .d 7230 to 7786 556 to 1       556/556
(100 %)
2 diff
(99.7 %id)
DB331425   .d 7234 to 7774 541 to 2       540/541
(99 %)
0 diff
(100 %id)
BI496201 cochlea, ear .d 7257 to 7765 1 to 509       509/509
(100 %)
5 diff
(99.1 %id)
BF914077 uterus_tumor .d 7262 to 7597 1 to 340       340/387
(87 %)
22 diff
(94.4 %id)
AW003195 pooled germ cell tumors .d 7275 to 7776 519 to 18   AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 502/502
(100 %)
10 diff
(98.1 %id)
N56971 multiple sclerosis lesions .d 7315 to 7777 465 to 1       465/466
(99 %)
2 diff
(99.6 %id)
BE550815 carcinoid, lung .d 7330 to 7783 487 to 35   AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 453/453
(100 %)
11 diff
(97.6 %id)
BX098129   .d 7334 to 7776 1 to 444   AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 444/444
(100 %)
2 diff
(99.6 %id)
BF915598 uterus_tumor .d 7335 to 7643 3 to 307       305/314
(97 %)
19 diff
(94.0 %id)
H99211 melanocyte .d 7354 to 7786 438 to 1       438/438
(100 %)
5 diff
(98.9 %id)
AA398852   .d 7372 to 7539 1 to 169   fully sequenced,   169/169
(100 %)
0 diff
(100 %id)
CA944842 Human Lung Epithelial cells, lung .d 7372 to 7776 2 to 406     Submitted on the opposite strand 405/408
(99 %)
9 diff
(97.8 %id)
FN089285 breast carcinoma .d 7378 to 7483 1 to 101       101/101
(100 %)
7 diff
(93.1 %id)
BE551866 pooled germ cell tumors .d 7386 to 7781 403 to 9       395/403
(98 %)
0 diff
(100 %id)
H99785 melanocyte .d 7396 to 7776 383 to 1       383/383
(100 %)
2 diff
(99.5 %id)
AA738390 pooled germ cell tumors .d 7396 to 7786 392 to 1       392/392
(100 %)
1 diff
(99.8 %id)
AW189519 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 7396 to 7776 404 to 24   AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 381/381
(100 %)
13 diff
(96.6 %id)
AA814090 germinal center B cell .d 7415 to 7776 372 to 12   AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 361/361
(100 %)
1 diff
(99.8 %id)
AW978100   .d 7417 to 7775 358 to 1     Submitted on the opposite strand 358/358
(100 %)
3 diff
(99.2 %id)
D59937   .d 7425 to 7749 19 to 343       325/343
(94 %)
6 diff
(98.3 %id)
AA443816   .d 7435 to 7780 345 to 1       345/346
(99 %)
1 diff
(99.8 %id)
AI768344 pooled .d 7456 to 7786 348 to 16   AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 333/335
(99 %)
15 diff
(95.6 %id)
DB325130   .d 7456 to 7786 332 to 1       332/332
(100 %)
1 diff
(99.7 %id)
AI469684 colon, moderately-differentiated adenocarcinoma .d 7457 to 7779 320 to 1       320/323
(99 %)
3 diff
(99.1 %id)
AI090304 B-cell, chronic lymphotic leukemia .d 7459 to 7792 336 to 4       333/336
(99 %)
0 diff
(100 %id)
CA310956 Human Lung Epithelial cells, lung .d 7460 to 7786 3 to 330   AAA Submitted on the opposite strand 328/330
(99 %)
6 diff
(98.2 %id)
AI267925 carcinoid, lung .d 7466 to 7775 311 to 1       311/312
(99 %)
1 diff
(99.7 %id)
H82065 melanocyte .d 7474 to 7759 289 to 1       289/289
(100 %)
4 diff
(98.7 %id)
AA551811 colon, tumor .d 7480 to 7778 299 to 1       299/299
(100 %)
0 diff
(100 %id)
AI521578 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .d 7487 to 7786 335 to 35   AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 301/301
(100 %)
8 diff
(97.4 %id)
BG150226 carcinoid, lung .d 7487 to 7773 287 to 1       287/287
(100 %)
2 diff
(99.4 %id)
N67421 cochlea, ear .d 7490 to 7786 299 to 2       298/299
(99 %)
0 diff
(100 %id)
AI739176 colon, colon tumor, RER+ .d 7494 to 7784 293 to 1       293/296
(98 %)
4 diff
(98.7 %id)
AA435856   .d 7509 to 7779 271 to 1   fully sequenced,   271/271
(100 %)
0 diff
(100 %id)
T25471   .d 7521 to 7781 261 to 1       261/261
(100 %)
8 diff
(97.0 %id)
AA741259 germinal center B cell .d 7553 to 7784 270 to 40   AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 231/231
(100 %)
1 diff
(99.6 %id)
BU674409 lung, Primary Lung Epithelial Cells .d 7587 to 7776 208 to 19   AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 190/290
(65 %)
0 diff
(100 %id)
NM_032440.3   .e 1 to 10387 4 to 10390   RefSeq,   10390/10390
(100 %)
3 diff
(100.0 %id)
DA532743 brain .e 1 to 344 4 to 347   tiling clone, capped   346/346
(100 %)
0 diff
(100 %id)
AB058698 brain .e 85 to 4831 1 to 4747   tiling clone, available from KIAA,   4747/4747
(100 %)
0 diff
(100 %id)
BX105330 liver and spleen .f 1 to 780 1 to 781 exact tiling clone,   781/781
(100 %)
2 diff
(99.8 %id)
TI_157614257   .f 395 to 916 609 to 88   AAA   522/523
(99 %)
2 diff
(99.7 %id)
CF528377 placenta .f 462 to 916 472 to 18   AAA   455/455
(100 %)
0 diff
(100 %id)
AI023992 liver and spleen .f 509 to 916 408 to 1       408/408
(100 %)
0 diff
(100 %id)
AI628679 Kidney .f 558 to 984 427 to 1   tiling clone,   427/427
(100 %)
3 diff
(99.3 %id)
AA705306 liver and spleen .f 563 to 916 354 to 1       354/354
(100 %)
1 diff
(99.8 %id)
BQ358984 head_neck .f 862 to 1136 1 to 273   tiling clone,   273/273
(100 %)
6 diff
(97.9 %id)
DA863465 placenta .g 1 to 650 2 to 651   tiling clone, capped   650/650
(100 %)
1 diff
(99.9 %id)
BE000818 breast_normal .g 593 to 863 270 to 1   tiling clone, Submitted on the opposite strand 270/285
(94 %)
1 diff
(99.7 %id)
CB989676 Human Placenta, placenta .h 1 to 769 28 to 804 A59G D60* tiling clone,   777/806
(96 %)
26 diff
(96.8 %id)
CD696928 normal nasopharynx .i -11 to 545 16 to 572   tiling clone, AAA   557/572
(97 %)
7 diff
(98.8 %id)
DB148564 thymus .i 1 to 561 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
DR003691 hippocampus .i 19 to 701 1 to 683 K55X tiling clone,   683/683
(100 %)
3 diff
(99.6 %id)
DA788606 brain .j 1 to 579 2 to 577 G33P P34V V35S S36L L37C ... tiling clone, capped   576/576
(100 %)
1 diff
(99.9 %id)
BF761899 colon_est .j 234 to 478 245 to 1     Submitted on the opposite strand 245/287
(85 %)
0 diff
(100 %id)
BI029242 marrow .k 1 to 389 389 to 1 exact tiling clone,   389/390
(99 %)
0 diff
(100 %id)
BI029025 marrow .k 9 to 468 470 to 10   tiling clone,   461/470
(98 %)
0 diff
(100 %id)
DB316146.
matches multiple genes
brain Gene zypyby, variant not shown         This clone was ignored, also hits gene zypyby    
DB316146.
matches multiple genes
brain Gene LCORandC10orf12, variant not shown         This clone was ignored, also hits gene zypyby    
DA507116.
matches multiple genes
brain Gene zypyby, variant not shown       capped This clone was ignored, also hits gene zypyby    
DA507116.
matches multiple genes
brain Gene LCORandC10orf12, variant not shown       capped This clone was ignored, also hits gene zypyby    
AA777765 liver and spleen Gene LCORandC10orf12, variant not shown         Suspected internal deletion, this clone was ignored    
BF063751 colon, colon tumor, RER+ Gene LCORandC10orf12, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI